Droplet Digital PCR for Rare Nucleic Acid Mutation Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting rare mitochondrial DNA deletions are limited by low sensitivity, making it difficult to detect de novo deletions and trace their kinetics, which is crucial for diagnosing and monitoring mitochondrial disorders such as Kearns-Sayre Syndrome and other diseases.
Innovation Solution
A method involving contacting nucleic acid molecules with a restriction endonuclease that cleaves wild-type molecules but not those with mutations, followed by amplification and quantification of the mutated regions using droplet digital PCR, allowing for the detection of rare mutations and determination of deletion sizes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current detection methods are used, then the detection process is simple, but the sensitivity is low and rare mutations cannot be detected
Solution Approach 1:
The detection method is segmented into distinct stages: restriction endonuclease treatment to differentiate wild-type and mutant molecules, selective amplification of mutant sequences, and droplet digital PCR for precise quantification. This segmentation allows each step to be optimized independently, achieving high sensitivity for rare mutation detection while maintaining procedural clarity
Solution Approach 2:
The restriction endonuclease treatment is performed as a preliminary action before amplification. This pre-treatment step modifies wild-type DNA molecules by introducing cuts or modifications that prevent their subsequent amplification, while mutant molecules remain intact and amplifiable. This preliminary differentiation step enables selective enrichment of rare mutant sequences from the background of wild-type sequences
2Measurement precision
If restriction endonuclease treatment is applied, then mutation detection sensitivity improves, but the detection process becomes more complex
Solution Approach 1:
The restriction endonuclease acts as an intermediary agent that mediates the differentiation between wild-type and mutant DNA molecules. By introducing site-specific modifications to wild-type sequences, the enzyme creates a molecular signature that enables subsequent selective amplification. This intermediary step transforms the detection problem from directly identifying rare mutations to selectively amplifying them based on their resistance to restriction enzyme treatment
Solution Approach 2:
The method replaces direct physical or chemical detection of mutations with a biological amplification system. Instead of attempting to directly detect or image rare mutant molecules among billions of wild-type molecules, the system uses PCR amplification to mechanically replicate and amplify only the mutant sequences, converting a detection problem into a quantification problem that can be solved with standard molecular biology tools
3Measurement precision
If droplet digital PCR is used for amplification and quantification, then detection sensitivity reaches 1 per 10^7 genomes, but the procedure becomes more complex
Solution Approach 1:
The method changes the physical parameters of the amplification system by using droplet digital PCR instead of conventional bulk PCR. This creates discrete, isolated reaction compartments where stochastic effects are minimized and absolute quantification becomes possible. The parameter change from bulk to partitioned amplification enables detection of extremely low-frequency mutations by providing a digital readout of mutant molecule numbers
Solution Approach 2:
The droplet digital PCR process creates multiple identical copies of the mutant DNA sequences through exponential amplification. Each positive droplet contains numerous copies of the original mutant molecule, allowing the signal from a single rare mutant to be amplified to detectable levels. This copying process transforms the undetectable signal from one mutant molecule among 10^7 wild-type molecules into a robust signal from thousands of mutant copies
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the sensitive detection of rare mutations at frequencies as low as 1 deletion per 10^7 genomes, facilitating early disease detection and monitoring of mitochondrial disorders.
Implementation Method 1
contacting a plurality of nucleic acid molecules with a first restriction endonuclease, wherein the first restriction endonuclease is capable of cleaving a nucleic acid molecule comprising a first target region having a site specific for the first restriction endonuclease
Implementation Method 2
amplifying the mutated first target region from the plurality of nucleic acid molecules of step (a) with a first 5′ primer and a first 3′ primer
Data Source
AI summary
The present disclosure relates to compositions and methods for detecting rare nucleic acid molecule mutations in a plurality of nucleic acid molecules. Also disclosed are methods for determining the size of a nucleic acid molecule using droplet digital PCR.